The mortality rate for malignant neoplasms of the colon, rectum, and anus in the US is forecasted to decrease from 15.7 deaths per hundred thousand persons in 2024 to 15.4 in 2028. This represents a year-on-year decrease of approximately 0.64% per year from 2024 to 2028. The data suggests a steady decline in mortality, following trends that may have started in previous years.
Future trends to watch for include advancements in early detection, increased effectiveness of treatments, and improving lifestyle changes, which could further drive down mortality rates. Monitoring healthcare policy shifts and their impact on access to care is also crucial.
